Company news
Xvivo Perfusion Ab (OMXSTO:XVIVO) news
Xvivo Perfusion Ab news releases on 6ix. Latest, Sep 28, 2026: XVIVO announces FDA receipt of PMA application for the XVIVO Heart Assist Transport System
Press releases & updates
XVIVO announces FDA receipt of PMA application for the XVIVO Heart Assist Transport System
September 28, 2026
XVIVO receives CE certificates for its groundbreaking heart preservation technology, transforming access to life-saving transplants across Europe
August 11, 2026
XVIVO granted additional patient enrollment in the US PRESERVE CAP study for XVIVO Heart Assist Transport
August 3, 2026
Interim Report January - June 2026
July 14, 2026
Regulatory Derogation and Reimbursement in France Enable Life-Saving Use of XVIVO's Heart Technology
May 18, 2026
Regulatory derogation and reimbursement in France enable life-saving use of XVIVO’s heart technology
May 18, 2026
Late-Breaking Data from PRESERVE Trial Evaluates XVIVO’s HOPE Preservation Approach in Heart Transplantation
April 22, 2026
The 12-Month Follow-up Results from XVIVO's European Multicenter Heart Trial is Now Published in the European Heart Journal
April 16, 2026
Notice To Attend the Annual General Meeting in XVIVO Perfusion Ab (Publ)
March 19, 2026
CORRECTION FROM SOURCE: The Nomination Committee's Proposal for New Board Members
February 20, 2026
The Nomination Committee of XVIVO Perfusion AB (publ) Proposes Emil Billbäck and Anne-Karen Hunt as New Members of the Board of Directors
February 20, 2026
Management Change at XVIVO - CFO Transitions to New Role
February 19, 2026
Change of Date for Publication of the Interim Report January-March 2026
February 10, 2026
XVIVO's CEO to present at J.P. Morgan's 44th Annual Healthcare Conference in San Francisco
January 6, 2026
Interim Report January-September 2025
October 23, 2025
Nomination Committee of XVIVO Perfusion AB (publ)
September 5, 2025
Delay in CE Approval for XVIVO's Perfusion Solution for Heart Preservation
July 28, 2025
First Patient Enrolled in US PRESERVE CAP Study for XVIVO Heart Assist Transport Device
July 21, 2025
Interim Report January-June 2025
July 11, 2025
XVIVO Honored with 2025 SACC-USA Business Award for Life-Saving Innovation and Growth in the U.S. Market
June 13, 2025
XVIVO Presents 12-Month Follow-Up Results from European Multicenter Heart Transplantation Trial at ISHLT in Boston
April 29, 2025
Bulletin from Annual General Meeting in XVIVO Perfusion AB (publ)
April 25, 2025
Interim Report January-March 2025
April 24, 2025